The higher levels of DNA-NE and DNA-MPO in patients with AE and severe bronchiectasis indicated that neutrophilic inflammation and NET formation are candidate biomarkers for evaluating bronchiectasis severity. The gene discussed is MPO; the disease is bronchiectasis.